Browse EX-10 agreements

July 16, 2026

VIA EMAIL

Henry Blynn

Dear Henry:

This letter (the “Amended and Restated Agreement”), effective as of the date hereof (the “Effective Date”), will confirm the terms of your employment with Stablecoin Development Corporation (f/k/a NovaBay Pharmaceuticals, Inc.), a Delaware corporation (the “Company”). You have previously provided services to the Company as a consultant pursuant to that certain Consulting Agreement dated October 16, 2025, as amended by that certain First Amendment to Consulting Agreement dated February 3, 2026 (collectively, the “Prior Consulting Agreement”), and as Head of Business Operations and Strategy pursuant to the employment agreement dated March 31, 2026, which this Amended and Restated Agreement amends and is being entered into in connection with the transition of your role as Head of Business Operations and Strategy to Chief Operating Officer of the Company. 

1.**    Position and Duties. **

…

FORM OF INDEMNIFICATION AGREEMENT

This Indemnification Agreement (this “Agreement”) is made and entered into as of [●], by and among Stablecoin Development Corporation, a Delaware corporation (the “Company”), and [●] (“Indemnitee”).

WHEREAS, in light of the litigation costs and risks to directors and officers resulting from their service to companies, and the desire of the Company to attract and retain qualified individuals to serve as directors and officers, it is reasonable, prudent and necessary for the Company to indemnify and advance expenses on behalf of the Company’s directors and/or officers to the fullest extent permitted by Delaware corporate law so that they will serve or continue to serve the Company free from undue concern regarding such risks;

WHEREAS, the Company has requested that Indemnitee serve or continue to serve as a director and/or officer of the Company and may have requested or may in the future request that Indemnitee serve one or more StableDev Entities (as hereinafter defined) as a director or an officer or in other capacities;

…

EIGHTH AMENDMENT

TO THE AMENDED AND RESTATED

LIMITED PARTNERSHIP AGREEMENT

OF

GENERATION INCOME PROPERTIES, L.P.

AND

SERIES B-1 STANDSTILL AND OMNIBUS CONSENT

Dated as of July 16, 2026

This Eighth Amendment to the Amended and Restated Limited Partnership Agreement of Generation Income Properties, L.P. and Series B-1 Standstill and Omnibus Consent (this “Amendment”) is made as of the date first written above by and among Generation Income Properties, Inc., a Maryland corporation (“GIPR”), individually and in its capacity as sole general partner of Generation Income Properties, L.P.; Generation Income Properties, L.P., a Delaware limited partnership (the “Partnership” or “GIPLP”); and LMB Owenton I LLC, a Kentucky limited liability company (the “B-1 Holder”). GIPR, GIPLP and the B-1 Holder are referred to collectively as the “Parties.”

Capitalized terms used but not defined in this Amendment have the meanings given to them in the Partnership Agreement.

RECITALS

…

NINTH AMENDMENT

TO THE AMENDED AND RESTATED

LIMITED PARTNERSHIP AGREEMENT

OF

GENERATION INCOME PROPERTIES, L.P.

AND

SERIES B-2 OMNIBUS CONSENT AND AMENDMENT

TO RELATED AGREEMENTS

Dated as of July 16, 2026

This Ninth Amendment to the Amended and Restated Limited Partnership Agreement of Generation Income Properties, L.P. and Series B-2 Omnibus Consent and Amendment to Related Agreements (this “Amendment”) is made as of the date first written above by and among Generation Income Properties, Inc., a Maryland corporation (“GIPR”), individually and in its capacity as sole general partner of Generation Income Properties, L.P.; Generation Income Properties, L.P., a Delaware limited partnership (the “Partnership” or “GIPLP”); and Lloyd M. Bernstein, individually and as the holder of record of the Series B-2 Preferred Units (“Bernstein”). GIPR, GIPLP and Bernstein are referred to collectively as the “Parties.”

Capitalized terms used but not defined in this Amendment have the meanings given to them in the Partnership Agreement or the B-2 Contribution Agreement, as applicable.

…

CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE

This Confidential Separation Agreement and General Release (the “Agreement”) is dated as of July 9, 2026, and entered into by and between Cadrenal Therapeutics, Inc., a Delaware corporation (together with each and every of its predecessors, successors (by merger or otherwise), partners, affiliates, joint venture partners, divisions, directors, officers, insurers, employees and agents, whether present or former, the “Company”), and James J. Ferguson III (hereinafter referred to as “you,” or “your”), to set forth our mutual agreement relating to your separation from employment with the Company.

NOW, THEREFORE, in consideration of the mutual covenants, agreements and promises hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

…

July 13, 2026

Eric M. Mellinger

[Intentionally omitted.]

[Intentionally omitted.]

Dear Eric,

Spire Global Subsidiary, Inc. (the “Company”) is pleased to offer you employment on the terms of this letter agreement (the “Agreement”):

1.

Position and Start Date. Your job title will initially be Chief Commercial Officer of Spire Global, Inc., and you will be working in our Tyson’s Corner, VA office. You will initially report to Theresa Condor, Chief Executive Officer. This is a full-time, exempt position. While you render services to the Company, you will not engage in any other employment, consulting or other business activity (whether full-time or part-time) that would create a conflict of interest with the Company. By signing this Agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company. You and the Company anticipate that your initial date of employment (your “Start Date”) will be August 3, 2026.

2.

Cash Compensation.

(a)

…

TRANSITION SERVICES AGREEMENT

This Transition Services Agreement (this “Agreement”) is made and entered into by and between Sam Hinrichsen (“Hinrichsen”) and Lindsay Corporation, a Delaware corporation (the “Company”) to become effective on the Effective Date (as defined in Section 14), on the terms and subject to the conditions set forth herein.

RECITALS

WHEREAS, Hinrichsen currently serves as Senior Vice President and Chief Financial Officer of the Company, but has notified the Company of his intention to leave the Company for personal reasons, with his employment to terminate effective August 31, 2026;

WHEREAS, in order to assure access to Hinrichsen’s unique and valuable services and an effective leadership transition, the Company desires to retain Hinrichsen to provide transition services for a specified transition period on the terms and conditions set forth herein; and

WHEREAS, Hinrichsen agrees to provide transition services to the Company during the specified transition period on the terms and conditions set forth herein;

…

Execution Version

ASSET REPRESENTATIONS REVIEW AGREEMENT

among

GM FINANCIAL CONSUMER AUTOMOBILE RECEIVABLES TRUST 2026-3,

Issuer

AMERICREDIT FINANCIAL SERVICES, INC.

D/B/A GM FINANCIAL,

Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,

Asset Representations Reviewer

Dated as of July 15, 2026

---

TABLE OF CONTENTS

| | | | | | | | | ------------------------------------------------------- | - | ----------------------------------------------------------- | : | - | -: | - | | | | | | | | | | ARTICLE I DEFINITIONS | | | | | 1 | | | Section 1.1. | | Definitions | | | 1 | |

…

Execution Version

**PURCHASE AGREEMENT **

**between **

**AFS SENSUB CORP. **

**Purchaser **

**and **

**AMERICREDIT FINANCIAL SERVICES, INC. **

**D/B/A GM FINANCIAL **

**Seller **

**Dated as of July 15, 2026 **

---

**TABLE OF CONTENTS **

| | | | | | | | | ----------------------------------------------------------------------------- | - | --------------------------------------------------------------------------- | : | :---: | -----: | ----- | | | | | | | | | | | | | | Page | | |

…

DEEP FISSION, INC.

2025 Equity Incentive Plan, as Amended

	1.	General

(a)            Plan Purpose. The Company, by means of the Plan, seeks to secure and retain the services of Employees, Directors and Consultants, to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such persons may be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards.

(b)            Available Awards. The Plan provides for the grant of the following Awards: (i) Incentive Stock Options; (ii) Nonstatutory Stock Options; (iii) SARs; (iv) Restricted Stock Awards; (v) RSU Awards; (vi) Performance Awards; and (vii) Other Awards.

(c)            Adoption Date; Effective Date. The Plan will come into existence on the Adoption Date, but no Award may be granted prior to the Effective Date.

…

EXECUTION COPY

FOURTH AMENDMENT
TO SENIOR SECURED REVOLVING CREDIT AGREEMENT

THIS FOURTH AMENDMENT TO SENIOR SECURED REVOLVING CREDIT AGREEMENT, dated as of July 14, 2026 (this “Amendment”), to the Existing Credit Agreement (capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in Article I) is among BAIN CAPITAL PRIVATE CREDIT, a Delaware statutory trust (the “Borrower”), solely with respect to Section 5.12herein, the SUBSIDIARY GUARANTORS party hereto, the LENDERS and ISSUING BANKS party hereto and SUMITOMO MITSUI BANKING CORPORATION, as Administrative Agent (the “Administrative Agent”) and, solely with respect to Section 5.11herein, as Collateral Agent (the “Collateral Agent”).

W I T N E S S E T H:

…

CORPORATE INTEGRITY AGREEMENT BETWEEN THE

OFFICE OF INSPECTOR GENERAL OF THE

DEPARTMENT OF HEALTH AND HUMAN SERVICES AND

EYEPOINT INC.

I.

PREAMBLE

EyePoint Inc. and all subsidiaries and any additional affiliated entities owned, controlled, or operated by EyePoint Inc. including those that may be created during the term of this CIA (collectively, “Entity”) hereby enters into this Corporate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of the United States Department of Health and Human Services (HHS) to promote compliance with the statutes, regulations, and written directives of Medicare, Medicaid, and all other Federal health care programs (as defined in 42 U.S.C. § 1320a-7b(f)) (Federal health care program requirements) and written directives of the Food and Drug Administration (FDA requirements). Contemporaneously with this CIA, Entity is entering into a Settlement Agreement with the United States.

II.

EFFECTIVE DATE, TERM, AND DEFINITIONS

A.

…